SD BIOSENSORSD BIOSENSORSD BIOSENSOR

SD BIOSENSOR

No trades
See on Supercharts
Market capitalization
‪1.26 T‬KRW
−4300KRW
‪−463.27 B‬KRW
‪620.56 B‬KRW
‪34.43 M‬
Beta (1Y)
1.24

About SD BIOSENSOR

Headquarters
Suwon-si
Employees (FY)
578
Founded
2010
ISIN
KR7137310009
FIGI
BBG0113G6LT3
SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. Its products include Standard Q, Standard F, Standard E, Standard M and BGMS. The company is founded on December 21, 2010 and is headquartered in Suwon-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 137310 is 10030 KRW — it has increased by 0.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SD BIOSENSOR stocks are traded under the ticker 137310.
137310 stock is 1.60% volatile and has beta coefficient of 1.24. Check out the list of the most volatile stocks — is SD BIOSENSOR there?
SD BIOSENSOR revenue for the last quarter amounts to ‪197.40 B‬ KRW despite the estimated figure of ‪243.55 B‬ KRW. In the next quarter revenue is expected to reach ‪350.60 B‬ KRW.
Yes, you can track SD BIOSENSOR financials in yearly and quarterly reports right on TradingView.
137310 stock has fallen by 8.23% compared to the previous week, the month change is a 11.32% fall, over the last year SD BIOSENSOR has showed a 54.10% decrease.
137310 net income for the last quarter is ‪−93.99 B‬ KRW, while the quarter before that showed ‪−64.12 B‬ KRW of net income which accounts for −46.59% change. Track more SD BIOSENSOR financial stats to get the full picture.
Today SD BIOSENSOR has the market capitalization of ‪1.22 T‬, it has decreased by 5.38% over the last week.
Like other stocks, 137310 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SD BIOSENSOR stock right from TradingView charts — choose your broker and connect to your account.
137310 reached its all-time high on Feb 4, 2022 with the price of 81000 KRW, and its all-time low was 9570 KRW and was reached on Oct 31, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 578.00 employees. See our rating of the largest employees — is SD BIOSENSOR on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SD BIOSENSOR technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SD BIOSENSOR stock shows the sell signal. See more of SD BIOSENSOR technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SD BIOSENSOR EBITDA is ‪−136.47 B‬ KRW, and current EBITDA margin is −17.81%. See more stats in SD BIOSENSOR financial statements.